GlaxoSmithKline and Pfizer are combining their consumer healthcare businesses in a multibillion-dollar merger. The two pharmaceutical giants — which own household names like Advil and Tums ...

Glaxo Wellcome and SmithKline Beecham completed their merger Wednesday to forge the world's leading drugs group by ... Firms Complete Merger of GlaxoSmithKline. L.A. Times Archives. Dec. 28, 2000 ...

The merger will bring together Pfizer’s big sellers like Centrum and Caltrate with GSK’s top brands, including Excedrin and Nicorette. GSK, which is headquartered in Britain, will own just ...

GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating an over-the-counter drug giant with combined sales of $12.7 billion. The new business will be spun off within three years.

British drugmaker GSK on Friday said it raised 885.6 million pounds ($1.08 billion) from a discounted stake sale in Haleon , cutting its shareholding to 7.4% in the world's largest standalone ...

GlaxoSmithKline gets US merger approval UK drugs giants Glaxo Wellcome and SmithKline Beecham have had their plans to merge cleared by the US Federal Trade Commission. The go-ahead is the final hurdle ...

GSK’s demerger of its consumer healthcare business, Haleon, will create a new independent firm, which we believe would have an implied market capitalization of just over $40 billion (based on ...

Shares in Haleon, created in a merger of GSK and Pfizer's , opens new tab consumer healthcare businesses in 2019, fell as much as 1.7% in morning trade, down 0.7% at 330.1 pence by 0730 GMT. GSK ...

Ingram, who went by Bob, led the British firm GlaxoWellcome through its merger to become GlaxoSmithKline. He joined Glaxo in 1990 and rose to head its U.S. operations, ...